Pollen Interference in EEM Hazardous-Substance Detection

2026-08-23

nor-NOHA Acetate: Arginase Research Workflows

2026-08-22

Build reproducible arginine-metabolism assays with nor-NOHA acetate, from enzyme-level validation to HepG2, endothelial, and exploratory AML immune-metabolism workflows. The reversible mechanism enables washout experiments that can separate arginase-dependent effects from lipid-driven immune signaling.

CFDA-SE: Linking Cell Division to Surface Biology

2026-08-21

CFDA-SE enables quantitative tracking of viable-cell division by flow cytometry. This guide develops a distinctive framework for pairing proliferation history with surface-protein organization, migration, and immune-cell behavior.

Capsazepine: A Framework for TRPV1 Assay Design

2026-08-20

Capsazepine is a TRPV1 ion channel antagonist that supports mechanistic studies of nociception, calcium signaling, TRPM8 responses, and apoptosis. This guide develops an assay-interpretation framework that connects channel pharmacology with the multidimensional pain findings of a 2026 cannabidiol study.

ML-Designed LNPs Reprogram Hyperactivated Microglia

2026-08-20

Rafiei, Shojaei, and Chau combined lipid nanoparticle library screening with supervised machine learning to identify carriers that deliver mRNA and alter inflammatory microglial states. The study highlights HA-LNP2 as a promising IL10 mRNA carrier while showing that model performance depends strongly on cellular activation state.

GCGR Allosteric Binding Sites: Insights from MD and Crystals

2026-08-19

Wang et al. integrate a resolved GCGR–MK-0893 crystal structure with dynamic receptor conformations, docking, binding free-energy analysis, and molecular dynamics to infer binding sites for related small molecules. The study provides a computational framework for interpreting allosteric recognition and prioritizing hypotheses for glucagon receptor antagonist design in type 2 diabetes research.

ATRNL1 and Cell-Specific Biology of Atrial Fibrillation

2026-08-19

The reference study applies large-scale single-nucleus RNA sequencing to human left atrial tissue, identifying cardiomyocyte- and macrophage-specific transcriptional changes associated with atrial fibrillation. Its functional experiments nominate ATRNL1 as a regulator of cellular stress responses and cardiac electrical activity, while also revealing an unexpected expression pattern for KCNN3.

Gepotidacin Reveals a New Gyrase Cleavage Mechanism

2026-08-18

The reference study defines how gepotidacin inhibits Staphylococcus aureus gyrase through a cleavage pattern distinct from that of fluoroquinolones. Its biochemical assays and crystal structures show potent supercoiling inhibition, persistent gyrase–DNA complexes, and selective single-stranded DNA cleavage, providing a mechanistic framework for developing antibacterial agents that can address fluoroquinolone resistance.

nor-NOHA: A Precision Lens on Immune Metabolism

2026-08-18

nor-NOHA acetate offers a mechanistic way to interrogate arginase-dependent control of arginine, nitric oxide, tumor behavior, and vascular signaling. When considered alongside recent evidence linking CD36-dependent lipid sensing to immune escape in AML, it becomes a strategic research tool for testing whether distinct nutrient-sensing pathways converge on translational resistance.

nor-NOHA Acetate: Applied Research Workflows

2026-08-17

nor-NOHA acetate gives researchers a reversible way to interrogate arginase–NOS competition, with practical workflows spanning HepG2 tumor assays, endothelial biology, and exploratory AML immunometabolism. This guide combines dosing, washout, orthogonal readouts, and troubleshooting while clearly separating established findings from hypotheses inspired by recent CD36 research.

G-1: Selective GPR30 Agonist Workflows

2026-08-17

G-1 enables controlled interrogation of rapid GPR30 signaling in calcium, PI3K, cancer-cell migration, cardiovascular, and spinal pain models. This guide translates receptor pharmacology into practical assay workflows, controls, optimization steps, and evidence-aware use cases.

CD36 Lipid Signaling and Immune Escape in AML

2026-08-16

Guo et al. identify a CD36-dependent, non-canonical lipid signaling program that enables AML cells to suppress T-cell activity and resist decitabine therapy. The study separates this immune mechanism from lipid oxidation and shows that lipid restriction with statins can improve hypomethylating-agent responses in experimental models.

PMSF Workflows for Protein Extraction and Western Blot

2026-08-15

Phenylmethanesulfonyl fluoride (PMSF) protects proteins from serine-protease-driven degradation during cell, tissue, and hemocyte extraction. This practical guide connects selective inhibition with Western blot preparation, apoptosis research, and time-resolved shrimp immunity assays while emphasizing fresh preparation and troubleshooting.

Pcbp1, Mitochondrial Integrity, and B Cell Immunity

2026-08-15

The reference study identifies the RNA-binding protein Pcbp1 as a posttranscriptional regulator of mitochondrial integrity, protein translation, and antibody responses in B cells. Its proposed Pcbp1–Fdxr axis connects RNA regulation with complex I maintenance, explaining defects in IgM production, germinal center differentiation, and high-affinity antibody generation.

Mitochondrial Calcium Signaling Represses Ferroptosis

2026-08-14

The reference study identifies a mechanistic connection between mitochondrial calcium uptake, acetyl-CoA-dependent GPX4 modification, and suppression of ferroptotic cell death. Its genetic rescue, structural, and tumor-model evidence suggests that mitochondrial calcium signaling can regulate ferroptosis through post-translational control of GPX4 activity.